Ciprofloxacin-13C3,15N (monohydrochloride)

Ciprofloxacin-13C3,15N (monohydrochloride)

• CAS Number: 2483830-12-0
• UNSPSC Description: Ciprofloxacin-13C3,15N (Bay-09867-13C3,15N) monohydrochloride is 13C- and 15N-labeled Ciprofloxacin (monohydrochloride) (HY-B0356A)[1].
• Target Antigen: Antibiotic; Apoptosis; Bacterial; Isotope-Labeled Compounds; Mitochondrial Metabolism; Reactive Oxygen Species; Topoisomerase
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection;Apoptosis;Cell Cycle/DNA Damage;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB;Others
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/ciprofloxacin-13c3-15n-monohydrochloride.html
• Purity: 99.9
• Solubility: H2O : 12.5 mg/mL (ultrasonic)
• Smiles: O=C1C2=CC(F)=C(N3CCNCC3)C=C2[15N](C4CC4)[13CH]=[13C]1[13C](O)=O.Cl
• Molecular Weight: 371.77
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Smith K A, et al. Soil and environmental analysis[M]. Marcel Dekker Incorporated, 2000.|[3]Fan T W M, et al. Stable isotope-resolved metabolomics and applications for drug development[J]. Pharmacology & therapeutics, 2012, 133(3): 366-391.
• Shipping Conditions: Blue Ice
• Storage Conditions: -20°C (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported